Crucible · Firm report card
GLYCAN THERAPEUTICS CORPORATION
NC · SBIR awardee across 1 federal program (HHS/NIH), first award 2013.
20SBIR awards
$17MSBIR $
13 → 7Phase I → II
$2MFollow-on federal $
2Follow-on contracts
SBIR awards by program
| Program | Awards | SBIR $ | Phase I | Phase II |
|---|---|---|---|---|
| HHS/NIH | 20 | $17M | 13 | 7 |
Mission areas
Open the interactive profile of GLYCAN THERAPEUTICS CORPORATION →Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.
Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology